News Archive from September 2009
September 24, 2009
A team of researchers from Thomas Jefferson University and the University of Delaware have received a grant from the Department of Defense to create a three-dimensional patient imaging system that will allow surgeons to view and touch selected organs and tissues prior to surgery.
September 23, 2009
Could Be First Step Leading to Effective Treatment of Soldiers Wounded in Combat Who Suffer From the Condition.
September 21, 2009
The current standard post-exposure regimen is not feasible in the developing world, where rabies is endemic. A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center.
September 18, 2009
The Jefferson Balance and Hearing Center of the Department of Otolaryngology – Head and Neck Surgery at Thomas Jefferson University Hospital is the first hospital in Philadelphia to offer the FDA-cleared Neuromonics Tinnitus Treatment. This therapy is proven to interact, interrupt and desensitize tinnitus by delivering a customized neural stimulus, embedded in clinically modified music.
September 16, 2009
Transplantation Expert to be Director of Live Donor Liver Transplant Program.
September 15, 2009
Thomas Jefferson University Hospital is the first hospital in Philadelphia, and the Delaware Valley, offering endoluminal fundoplication (ELF) – an incisionless surgical treatment option to provide long-term elimination of gastroesophageal reflux disease (GERD), one of the most common gastrointestinal diseases affecting hundreds of thousands of people, in which the esophagus becomes inflamed by digestive acid backing up from the stomach, resulting in heartburn.
September 02, 2009
Directly inhibiting the activity of a key protein mediator of inflammation reduced radiation toxicity in zebrafish embryos, and may ultimately be of help to patients receiving radiation therapy, according to researchers from the Kimmel Cancer Center at Jefferson.
September 02, 2009
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.